Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001193125-15-095469
Filing Date
2015-03-17
Accepted
2015-03-17 16:39:38
Documents
15

Document Format Files

Seq Description Document Type Size
1 FORM F-3/A d894949df3a.htm F-3/A 327436
2 EX-4.3 d894949dex43.htm EX-4.3 11630
3 EX-4.5 d894949dex45.htm EX-4.5 11620
4 EX-4.7 d894949dex47.htm EX-4.7 11737
5 EX-4.9 d894949dex49.htm EX-4.9 11629
6 EX-4.11 d894949dex411.htm EX-4.11 11625
7 EX-4.13 d894949dex413.htm EX-4.13 11741
8 EX-4.16 d894949dex416.htm EX-4.16 11626
9 EX-4.17 d894949dex417.htm EX-4.17 11624
10 EX-5.1 d894949dex51.htm EX-5.1 15719
11 EX-23.1 d894949dex231.htm EX-23.1 6611
12 EX-23.3 d894949dex233.htm EX-23.3 7498
13 GRAPHIC g894949g54t81.jpg GRAPHIC 2706
14 GRAPHIC g894949g55y75.jpg GRAPHIC 5696
15 GRAPHIC g894949g56c59.jpg GRAPHIC 2918
  Complete submission text file 0001193125-15-095469.txt   467504
Mailing Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077
Business Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: F-3/A | Act: 33 | File No.: 333-201767 | Film No.: 15707242
SIC: 2834 Pharmaceutical Preparations